Quince Therapeutics, Inc. - 8-K Filing
Quince Therapeutics sold Quince SpA and related assets to Ayma Therapeutics for $450,000 in cash; Charles Ryan received a severance package of $1.01 million. (Items: 2.01 Completion of Acquisition or Disposition of Assets, 9.01 is filed as Exhibit 99, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $QNCX